홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1-tert-Butyl 4-ethyl 5-oxoazepane-1,4-dicarboxylate → 1-Tert-butyl 4-ethyl 6-methyl-5-oxoazepane-1,4-dicarboxylate

HRID 2077048
인쇄

반응식

HRID 2077048 반응식
[O:1]=[C:2]1[CH2:8][CH2:7][N:6]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:5][CH2:4][CH:3]1[C:16]([O:18][CH2:19][CH3:20])=[O:17].[CH3:21]C1C(=O)CCN(C(OC(C)(C)C)=O)C1>>[CH3:21][CH:8]1[CH2:7][N:6]([C:9]([O:11][C:12]([CH3:15])([CH3:14])[CH3:13])=[O:10])[CH2:5][CH2:4][CH:3]([C:16]([O:18][CH2:19][CH3:20])=[O:17])[C:2]1=[O:1]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 44365701-tert-Butyl 4-ethyl 5-oxoazepane-1,4-dicarboxylateHCID 22644642tert-Butyl 3-methyl-4-oxopiperidine-1-carboxylate

생성물 1

HCID 593122241-Tert-butyl 4-ethyl 6-methyl-5-oxoazepane-1,4-dicarboxylate수율 100%

실험 절차

The title compound was prepared by a similar method to that of 1-tert-butyl 4-ethyl 5-oxoazepane-1,4-dicarboxylate (see WO2006029154, example 1a, p 34) from Tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate, yielding 100% of title compound which was taken on for pyrimidone formation without further purification.

출처 및 근거

ORD 기록
ord-9df31737def54ed988f99634e85b2c4f
출처 데이터셋
uspto-grants-2011_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07928099B2

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트